Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Quick Stats
Feb 02, 202666.8
AI Score
BUY1.23
Volume Ratio
Feb 04, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
NVS Stock Summary
Last updated Feb 02, 2026
NVS is currently trading at $151.04, positioned above its 200-day moving average of $125.21, indicating a long-term uptrend. The stock has a 52-week range of $97.715 to $152.48.
Technical Analysis: The 50-day moving average stands at $138.03, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 67.738, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.221, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NVS at 66.8/100 with a BUY recommendation.
NVS (Novartis AG) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 67.738 |
| CMF (20) | 0.221 |
| ROC (10) | 4.642 |
| ADX (14) | 30.701 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 3.472 |
| AROONOSC (14) | 71.429 |
| WILLAMS %R (14) | -12.323 |
| MFI (14) | 72.616 |
NVS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NVS Price vs Max Options Open Interest
NVS Max Change In Options Open Interest
NVS Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NVS Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NVS Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NVS Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Novartis AG is above both 50 Day and 200 Day SMA which is considered Bullish.
NVS Moving Averages Analysis
Novartis AG has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
Novartis AG has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
NVS (Novartis AG) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 147.88 |
| 20 | 145.05 |
| 30 | 142.69 |
| 50 | 138.03 |
| 100 | 132.82 |
| 200 | 125.21 |
NVS Fundamental Analysis
| P/E (Forward) | 16.2338 |
| P/E (Trailing) | 20.3671 |
| Market Cap ($) | 285.3 billion |
| Earnings/Share ($) | 7.3 |
| Net Proft Margin (%) | 0.2553 |
| Dividend/Share ($) | 3.862 |
| EPS Estimate Current Year ($) | 8.9198 |
| EPS Estimate Next Year ($) | 9.2289 |
| WallStreet Target Price ($) | 140.0022 |
| Most Recent Quarter |